COX-2-specific inhibitor or proton pump inhibitor plus traditional NSAID: Is either approach sufficient for patients at highest risk of NSAID-induced ulcers?

被引：8

作者：

Cryer, B ^{[1
]}

机构：

[1] Univ Texas, SW Med Sch, Dept Med, Dallas VA Med Ctr,Div Gastroenterol, Dallas, TX 75230 USA

来源：

GASTROENTEROLOGY | 2004年 / 127卷 / 04期

关键词：

D O I：

10.1053/j.gastro.2004.08.029

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1256 / 1258

页数：3

共 17 条

[1] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[2] Celecoxib versus diciofenac plus omeprazole in high-risk arthritis patients: Results of a randomized double-blind trial [J].

Chan, FKL ;

Hung, LCT ;

Suen, BY ;

Wong, VWS ;

Hui, AJ ;

Wu, JCY ;

Leung, WK ;

Lee, YT ;

To, KF ;

Chung, SCS ;

Sung, JJY .

GASTROENTEROLOGY, 2004, 127 (04) :1038-1043

[3] Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis [J].

Chan, FKL ;

Hung, LCT ;

Suen, BY ;

Wu, JCY ;

Lee, KC ;

Leung, VKS ;

Hui, AJ ;

To, KF ;

Leung, WK ;

Wong, VWS ;

Chung, SCS ;

Sung, JJY .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (26) :2104-2110

[4] Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen [J].

Chan, FKL ;

Chung, SCS ;

Suen, BY ;

Lee, YT ;

Leung, WK ;

Leung, VKS ;

Wu, JCY ;

Lau, JYW ;

Hui, Y ;

Lai, MS ;

Chan, HLY ;

Sung, JJY .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (13) :967-973

[5] Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans [J].

Cryer, B ;

Feldman, M .

GASTROENTEROLOGY, 1999, 117 (01) :17-25

[6] Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy - A Nordic multicentre study [J].

Ekstrom, P ;

Carling, L ;

Wetterhus, S ;

Wingren, PE ;

AnkerHansen, O ;

Lundegardh, G ;

Thorhallsson, E ;

Unge, P .

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (08) :753-758

[7]

Hawkey C, 2000, ARTHRITIS RHEUM-US, V43, P370, DOI 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO

[8]

2-D

[9] A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucose of patients with osteoarthritis [J].

Laine, L ;

Harper, S ;

Simon, T ;

Bath, R ;

Johanson, J ;

Schwartz, H ;

Stern, S ;

Quan, H ;

Bolognese, J .

GASTROENTEROLOGY, 1999, 117 (04) :776-783

[10] Stratifying the risk of NSAID-related upper gastrointestinal clinical events: Results of a double-blind outcomes study in patients with rheumatoid arthritis [J].

Laine, L ;

Bombardier, C ;

Hawkey, CJ ;

Davis, B ;

Shapiro, D ;

Brett, C ;

Reicin, A .

GASTROENTEROLOGY, 2002, 123 (04) :1006-1012

← 1 2 →